as of those of Pneumocystis carinii and Pneumocystis murina infecting respectively rats and 23 mice. In absence of an established in vitro culture method for Pneumocystis species, we used 24 functional complementation of the Saccharomyces cerevisiae gsc1 deletant. In the fungal 25 pathogen Candida albicans, mutations leading to amino acid substitutions in Gsc1 confer 26 resistance to caspofungin. We introduced the corresponding mutations into the Pneumocystis 27 gsc1 genes using site-directed mutagenesis. In spot dilution tests, the sensitivity to caspofungin 28 of the complemented strains decreased with the number of mutations introduced, suggesting 29 that the wild-type enzymes are sensitive. The minimum inhibitory concentrations of 30 caspofungin determined by E-test® and Yeastone® for strains complemented with Pneumocystis 31 enzymes (respectively 0.125 and 0.12 microg/ml) were identical to those upon INTRODUCTION 41 The Pneumocystis genus comprises fungal species that colonize the lungs of mammals (1) (2) (3) (4) . 42 Each of them displays strict host specificity for a single mammalian species. The species 43 infecting humans is Pneumocystis jirovecii, an opportunistic pathogen that can cause fatal 44 pneumonia if not treated (Pneumocystis pneumonia, PCP). The most efficient drug against P. 45 jirovecii is currently cotrimoxazole, a combination of sulfamethoxazole and trimethoprim, two 46 inhibitors of enzymes that are involved in the folic acid biosynthesis pathway. However, 47 resistance is emerging due to the selection of isolates carrying specific mutations in the active 48 site of the targets of both molecules (5-9). Moreover, cotrimoxazole can cause important side 49 effects in some patients, such as intolerance and toxicity. For these reasons, it is crucial to find 50 new drugs to treat PCP. 51 Echinocandins constitute an alternative class of antifungal drugs to consider for the 52 treatment of PCP. This class includes caspofungin (CAS), anidulafungin, and micafungin. They 53 are cyclic hexapeptides with fatty acyl side chains and act as non-competitive inhibitors of the 54 catalytic subunit Gsc1 of the 1,3-β glucan synthase enzymatic complex (10). β-glucan molecules 55 are components of the cell wall that are homopolymers of β-1,3 linked D-glucose with β -1,6 56 linked D-glucose side chains present in minority. The Gsc1 protein of Pneumocystis carinii, the 57 species infecting rats, was reported to be inhibited by the compound L-733,560, a molecule 58 structurally close to echinocandins (11). Recently, we identified and functionally ascertained 59 the function of the Gsc1 subunit of P. jirovecii using complementation of the orthologous gene 60 of Saccharomyces cerevisiae (12) . The presence of a unique gsc1 gene in the genome of P. 61 5 jirovecii, as in that of P. carinii, further suggests that the Gsc1 subunit is a potential new drug 62 target to fight PCP. 63 In S. cerevisiae, the 1,3-β glucan synthase catalytic subunit is encoded by two different 64 genes, GSC1 and GSC2. A third paralog, GSC3, is also present but it is involved only during 65 sporulation. The two subunits GSC1 and GSC2 are functionally redundant, but their expression 66 is differentially regulated. The expression of GSC1 is constitutive and responsible for the cell 67 wall synthesis during the vegetative growth, while that of GSC2 is induced by glucose 68 deprivation or pheromones and is also involved in cell wall synthesis during sporulation. GSC1 69 and GSC2 genes have an essential overlapping function, i.e., only disruption of both genes is 70 lethal. Importantly, the GSC2 gene can replace the function of the GSC1 gene during vegetative 71 growth in the case of loss by mutation or deletion (13). The S. cerevisiae strain with a deletion 72 of the GSC1 gene shows a reduced and impaired growth in presence of CAS (14) or 73 anidulafungin (15), but not of micafungin (15). On the other hand, the S. cerevisiae wild type 74 shows a normal growth in presence of low doses of CAS and anidulafungin, but its growth is 75 severely impaired in presence of micafungin. These observations showed that the S. cerevisiae 76 Gsc1 and Gsc2 subunits have different sensitivities to each echinocandin despite that their 77 identity at the amino acids sequence level is as high as 87% over the whole protein, with 81 and 78 94% identity at the level of the 1,3-β glucan synthase domains 1 and 2, respectively (Table 1) . 79 To our knowledge, the polymorphisms responsible for these different sensibilities have not 80 been determined so far. 81 Spontaneous mutants resistant to echinocandins were initially isolated in S. cerevisiae and 82 Candida albicans (16) (17) (18) . Rare clinical isolates of C. albicans were also found to be resistant (19, 83 6 20). A specific substitution of a serine in position 645 to a proline (S645P) was identified in all 84 spontaneous and most clinical resistant C. albicans isolates (20). It is localized within a highly 85 conserved region of the Gsc1 protein in which other mutations conferring resistance to CAS 86 were also identified in C. albicans (20) . This "Hot Spot no. 1" of mutations starts at residue 641 87 and ends at residue 649 of C. albicans Gsc1. A second but less relevant hotspot of mutations 88 conferring resistance has been identified in another region of the enzyme, from residue 1357 to 89 residue 1364. The S645P substitution has been most frequently observed, F641S being the 90 second most frequent substitution (21). The mutation corresponding to the C. albicans S645P 91 substitution introduced by site-directed mutagenesis was found to confer reduced 92 susceptibility to CAS in vitro to the mould Aspergillus fumigatus (22, 23) . 93 Although demonstrated against P. carinii and P. murina in rodent models (10, 24-28), the 94 efficacy of CAS against P. jirovecii remains controversial. Indeed, clinical reports documented 95 the clearance of PCP treated with CAS alone (29-31), or used in combination with cotrimoxazole 96 (32-36) or clindamycin (37). However, failures of CAS treatment were also described (38, 39) . 97 Despite the generally high conservation of active sites among orthologous enzymes, one cannot 98 exclude that the sensitivity to CAS may vary among P. jirovecii and the two Pneumocystis 99 species infecting rodents because these species are relatively distant from each other (20% of 100 mean divergence at nucleotide level in genomic coding sequences, 40). The P. jirovecii Gsc1 101 subunit bears 90 and 91% identity with those of P. carinii and P. murina, respectively (Table 1) . 102 At the level of the 1,3-β glucan synthase domains 1 and 2, i.e., the active sites, the identities are 103 from 94 to 97%. These values are comparable to those between the Gsc1 and Gsc2 subunits of 104 7 S. cerevisiae (see above), which present drastically different sensitivities to the different 105 echinocandins. 106 The aim of the present study was to determine if the Gsc1 subunit of P. jirovecii is 107 sensitive to the echinocandin CAS, as those of P. carinii and P. murina. To investigate the issue, 108 we analysed the level of sensitivity of S. cerevisiae strains functionally complemented by the 109 expression of the wild-type or mutated enzymes of the three Pneumocystis species. Sabouraud medium (0.5% wt/vol casein peptone, 0.5% meat extract peptone, 2% glucose), and 124 then grown on minimal solid yeast nitrogen base (YNB) medium (0.67% wt/vol yeast nitrogen 125 base, 2% glucose, 2% Gibco agar) supplemented with a complete supplement mixture (CSM, 126 MP Biomedicals). 9 jirovecii and S. cerevisiae gsc1 genes was previously described (12). Since the P. carinii and P. 134 murina gsc1 genes include each three introns, their cDNAs were synthesized and cloned into 135 the p416GPD vector (41) by GeneCust Europe (Ellange Luxemburg). Their size without introns is 136 respectively 5835 bps and 5847 bps. 137 To perform a control of sensitivity of our heterologous expression model, the GSC1 138 genes of C. albicans (GenBank D88815) and C. parapsilosis (EU221325) were amplified by PCR 139 from yeast genomic DNA extracted as described previously (42). The detailed procedures of 140 PCR amplification using the proofreading high-fidelity Expand polymerase (Roche Diagnostics) 141 and cloning were described previously (43). Their sizes are respectively 5694 and 5730 pbs. PCR 142 primers and conditions are listed in Tables S1 and S2. Because these primers were intended for 143 oriented cloning, they were designed to create unique restriction sites at ends of the PCR 144 products. After the PCR reactions, the products were extracted using the QIAquick gel 145 extraction kit (Qiagen, Basel, Switzerland). For cloning each Candida GSC1 gene into the 146 p416GPD expression vector, the double restriction described in Table S1 were used. Table S1 . Mutagenesis amplification reactions and PCR conditions are described in Table S2 . 164 Sequencing of both strands was performed thanks to the two primers used for amplification, as Test of complementation and susceptibility to caspofungin. Before studying the sensitivity to 181 echinocandins, we had to assess the function of the P. carinii and the P. murina gsc1 genes, as 182 we previously carried out for the P. jirovecii gsc1 gene (12) Table S3 . Serial dilution of the transformed strains were spotted on medium containing or 221 not CAS (spot dilution test, Fig. 1) . The deletion of the GSC1 gene in S. cerevisiae causes a 222 paradoxical effect, i.e., an increased susceptibility to CAS, though the target of CAS is absent 223 (14). This is due to the replacement of Gsc1 by Gsc2, an enzyme that is more sensitive to CAS 224 (13). On medium supplemented with CAS, a complete restoration of the wild-type growth was 225 observed in presence of the control S. cerevisiae GSC1 gene, but not in the presence of the 226 empty vector (Fig. 1) . A partial restoration was observed in the presence of the P. carinii or P. 227 murina gene, as we previously reported for P. jirovecii and reproduced here (Fig. 1) . These protein were aligned with those of C. albicans, S. cerevisiae, and C. parapsilosis (Fig. 2;   239 alignment of the complete proteins is shown in Fig. S1 ). This alignment identified the positions 240 in the three Pneumocystis gsc1 genes corresponding to the C. albicans F641S and S645P 241 substitutions. Site-directed mutagenesis was used to introduce one or two mutations encoding 242 the corresponding substitutions within the gsc1 gene of P. jirovecii, P. carinii, or P. murina (the 243 polymorphisms introduced at the nucleotide sequence level are described in Table S1 ). 244 The partial restoration of the wild-type growth on CAS observed with the P. jirovecii Gsc1 245 enzyme increased in presence of one mutation, and increased more upon introduction of the 246 two mutations simultaneously (Fig. 1) . Similarly, the partial restoration with the P. carinii or P. Minimum inhibitory concentration (MIC) assessment using E-test® and Sensititre YeastOne®. 252 We determined the MICs of CAS for the S. cerevisiae WT and complemented gsc1 deletant 253 strains. To assess the sensitivity of the two methods, we also analysed C. albicans and 254 15 C. parapsilosis, as well as the S. cerevisiae gsc1 deletant complemented with the GSC1 gene of 255 these two Candida species. The former Candida species is susceptible to CAS, whereas the 256 latter is considered as resistant (47, 48) . The natural resistance of C. parapsilosis is due to a 257 polymorphism at the end of the hotspot no. 1 (P660A), which has not been observed in C. 258 albicans so far (49; Fig. 2 ). In agreement with the spot dilution tests described here above, we 259 observed using both E-test® and YeastOne® an increased susceptibility of the S. cerevisiae gsc1 260 deletant compared to the WT (respectively 0.125 and 0.12 versus 0.250 and 0.25 g/ml; Table   261 2; the E-test results are shown in Fig. S3 ). All S. cerevisiae strains complemented with the 262 Pneumocystis wild-type or mutated genes had MICs identical to those of the gsc1 deletant 263 (0.125 for E-tests and 0.12 for Yeastone). The decreased sensitivity to CAS conferred by the 264 mutations introduced was not detected using both methods. Thus, these methods are less 265 sensitive than the spot dilution test used above since the latter always allowed detection of this 266 decrease in several experiments. The MIC values for C. albicans whole cells using E-test® and 267 YeastOne® were similar to those for the S. cerevisiae WT strain (0.380 and 0.12 versus 0.250 268 and 0.25), whereas, consistently with its resistance to CAS, C. parapsilosis had higher MICs using 269 both methods (0.500 and 8.00). The decreased sensitivity of C. parapsilosis was also detected to CAS, and this to a similar level. Because CAS has been demonstrated to be effective against 285 P. carinii and P. murina in rodent models (26, 27) , this observation suggested that CAS is also 286 effective against P. jirovecii. Moreover, MICs determination showed that the level of sensitivity 287 of Pneumocystis Gsc1 was similar to that of the C. albicans enzyme, suggesting that the 288 sensitivity of the Pneumocystis enzymes is at a level that is usable clinically. It is of course 289 difficult to translate our results obtained at the enzyme level to the whole cell level. 290 Nevertheless, Gsc1 is a cell surface enzyme that is easily reachable by drugs, and thus more 291 likely to behave similarly among the three Pneumocystis species. A structural difference of the 292 cell wall could induce varying sensitivity to CAS of the Gsc1 subunit among the three 293 Pneumocystis species. However, there is presently no obvious reasons to think that the wall of 294 P. jirovecii is different from those of P. carinii and P. murina. Finally, our results support the high 295 relevance of the animal models as tools to understand the effect of CAS on the human 296 pathogen P. jirovecii. 297 17 Studies in animal models showed that echinocandins provoke the disappearance of P. 298 carinii and P. murina asci but not of the trophic forms, probably because the latter cells have no 299 or little cell wall made of 1,3-β glucan (26). Thus, the treatment did not eradicate the infection, 300 and its cessation resulted in the repopulation in asci from the remaining trophic cells. 301 Consequently, it is likely that CAS is useful only if used in combination with another therapy 302 targeting trophic forms, or both cellular forms such as cotrimoxazole. CAS inhibited efficiently 303 the dissemination of the pathogen in animal models (26), which is consistent with the fact that 304 asci are believed to be the transmission particles (26, 50) . This feature of CAS might prove 305 useful in the management of infected and susceptible patients within the hospital by inhibiting 306 interhuman transmission of P. jirovecii. 307 In conclusion, our results demonstrate that the human pathogen P. jirovecii Gsc1 enzyme 308 is sensitive to caspofungin, similarly to the enzymes of the animal pathogens P. carinii and P. Table S3 . Sequence identity (%) of the S. cerevisiae Gsc1 protein to the ortholog proteins studied 
